Insider trades
Raymond Debbane, Director of Lexicon Pharmaceuticals LXRX, has filed 11 purchases and 15 sales on the open market. Over the past 12 months that comes to a net purchase of $2.7M. The latest trade was on 06/03.
Raymond Debbane
Director
- Company
- Lexicon Pharmaceuticals LXRX
- First filing
- 23/01/04
- Trades
- 50 trades
- Buys / sales
- 11 / 15
- 12-month net buying
- $2.7M
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 02/25 | 02/27 | 2,000 sh | $1.49 | $2,980 | +0.1% | |
| Open-market buy | 02/23 | 02/25 | 100,000 sh | $1.47 | $147,000 | +5.5% | |
LXRX | Open-market buy | 02/19–02/20 | 02/23 | 150,000 sh2 trades | $1.47avg. | $220,000 | +9.1% |
LXRX | Open-market buy | 02/13–02/18 | 02/18 | 268,497 sh3 trades | $1.31avg. | $353,067.95 | +19.4% |
| Open-market buy | 02/02 | 02/04 | 1,538,462 sh | $1.30 | $2,000,000.6 | No record | |
| Open-market sale | 24/12/10 | 24/12/12 | 1,600,000 sh | $41.65 | $66,640,000 | −14.7% | |
SRRK | Open-market sale | 24/11/25 | 24/11/27 | 409,433 sh5 trades | $38.49avg. | $15,757,297.83 | −3.6% |
CBIO | Open-market sale | 24/08/07–24/08/08 | 24/08/09 | 322,361 sh2 trades | $0.19avg. | $60,633.71 | −4.9% |
CBIO | Open-market sale | 24/08/05–24/08/06 | 24/08/07 | 220,255 sh2 trades | $0.19avg. | $41,291.13 | −3.2% |
CBIO | Open-market sale | 24/08/01–24/08/02 | 24/08/05 | 349,764 sh2 trades | $0.20avg. | $71,224.08 | −4.9% |
CBIO | Open-market sale | 24/07/26–24/07/30 | 24/07/30 | 1,379,119 sh3 trades | $0.23avg. | $315,851.86 | −16.1% |
LXRX | Open-market buy | 23/10/10–23/10/12 | 23/10/12 | 1,000,000 sh3 trades | $1.10avg. | $1,103,057.36 | +293.4% |
